SARS-CoV-2: fear versus data.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
May 2020
Historique:
received: 09 03 2020
accepted: 14 03 2020
pubmed: 24 3 2020
medline: 29 5 2020
entrez: 24 3 2020
Statut: ppublish

Résumé

SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-CoV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.

Identifiants

pubmed: 32201354
pii: S0924-8579(20)30097-2
doi: 10.1016/j.ijantimicag.2020.105947
pmc: PMC7102597
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105947

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Pathog Glob Health. 2016 May;110(3):113-8
pubmed: 27195607
Med Mal Infect. 2018 Mar;48(2):141-144
pubmed: 29402475
J Clin Microbiol. 2006 Jun;44(6):2063-71
pubmed: 16757599
Open Forum Infect Dis. 2017 Mar 25;4(2):ofx052
pubmed: 28616442
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Infect Dis. 2018 May 5;217(11):1728-1739
pubmed: 29741740
J Travel Med. 2020 May 18;27(3):
pubmed: 32109273
Virol J. 2016 Feb 01;13:18
pubmed: 26833249
Lancet Infect Dis. 2018 Aug;18(8):e217-e227
pubmed: 29680581
J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8
pubmed: 23977429
Asian J Psychiatr. 2020 Mar;49:101989
pubmed: 32143142
Emerg Infect Dis. 2015 Aug;21(8):1302-10
pubmed: 26196165
BMC Infect Dis. 2016 Oct 24;16(1):597
pubmed: 27776489
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Clin Virol. 2018 Apr;101:52-56
pubmed: 29427907
PLoS One. 2018 Jan 29;13(1):e0191789
pubmed: 29377913
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Emerg Infect Dis. 2018 Oct;24(10):1964-1966
pubmed: 30226169
Health Sci Rep. 2018 Jul 18;1(8):e59
pubmed: 30623094
Cell Stress. 2020 Mar 02;4(4):66-75
pubmed: 32292881
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1725-1733
pubmed: 30033505
PLoS One. 2014 Jul 31;9(7):e99782
pubmed: 25080241
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
PLoS One. 2014 Feb 03;9(2):e86448
pubmed: 24498274
Emerg Microbes Infect. 2019;8(1):339-352
pubmed: 30866787
N Engl J Med. 2003 Dec 18;349(25):2431-41
pubmed: 14681510
Eur J Pediatr. 2008 Dec;167(12):1427-34
pubmed: 18335238
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):363-369
pubmed: 29214503

Auteurs

Yanis Roussel (Y)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.

Audrey Giraud-Gatineau (A)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Service de Santé des Armées, Vecteurs - Infections Tropicales et Méditerranéennes, Marseille, France; Centre d'Epidémiologie et de Santé Publique des Armées, Marseille, France; Assistance Publique - Hôpitaux de Marseille, Marseille, France.

Marie-Thérèse Jimeno (MT)

Assistance Publique - Hôpitaux de Marseille, Marseille, France.

Jean-Marc Rolain (JM)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.

Christine Zandotti (C)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.

Philippe Colson (P)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.

Didier Raoult (D)

Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France. Electronic address: didier.raoult@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH